… a Rates for upgrade of excised intraductal papillomas without atypia (IP) to malignancy on
needle core biopsy (NCB). b Natural history of IPs on NCB undergoing active surveillance (…

… natural history of progression from low-grade DCIS to invasive carcinoma is uncertain.
Given the current thinking about possible overdiagnosis and overtreatment of DCIS, it is time to …

… with atypia compared with those without atypia did not differ with regard to personal history
… Table 1 Patient demographic and clinical features of the 129 intraductal papillomas studied: …

… had either a concurrent breast cancer or a history of breast cancer. Therefore, if we had
excised only select patients with either concurrent or prior history of breast cancer, two of our 104 …

… disease was upstaged, there was no statistically significant difference in family history of
breast cancer, indication for core biopsy, mammographic findings, or location of papilloma. …

… Based on the history, clinical features and the nature of the growth, a provisional diagnosis
of irritational fibroma was considered. Differential diagnoses of fibrosed mucocele, peripheral …

… papilloma. The most common benign papillary lesion is that of an intraductal papilloma (IDP). …
, ethnicity, a family history of breast cancer, a personal history of previous breast diseases, …

Background The long-term risk for patients with benign intraductal papillomas (IDPs) on core
needle biopsy (CNB) who are not upgraded on excision is not well-defined. The goal of this …

Background Available retrospective data suggest the upgrade rate for intraductal papilloma (IP)
without atypia on core biopsy (CB) ranges from 0 to 12%, leading to variation in …

… The patient was a 55-year-old woman with a medical history significant for lumpectomy in …
to reveal intraductal papilloma. Follow-up excision showed residual intraductal papilloma with …